Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 8, 2000, Pages 2154-2163

  Solomon, Abraham ^d   Li, De Quan ^d   Lee, Sao Bing ^a   Tseng, Scheffer C G ^b,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; COLLAGENASE; CYTOKINE; GELATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ARTICLE; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; EPITHELIUM CELL; EXCISION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; RELIABILITY; WESTERN BLOTTING; ZYMOGRAPHY;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGENASES; CONJUNCTIVA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PTERYGIUM; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033948687     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cameron ME. Histology of pterygium: an electron microscopic study. BrJ Ophthalmol. 1983;67:604-608.
2. Cilova-Atanasova B On the pathogenesis of pterygium. Folia Medica. 1971;13:67-72.
3. Hill JC, Maske R. Pathogenesis of pterygium. Eye. 1989;3:218-226.
4. Mortada A, Hamdi IE, Shiwi TE, El-Einein GA. Histopathology of recurrent true pterygium. Bull Ophth Soc Egypt. 1968;61:117-122.
5. Tan DTH, Chee S-P, Dear KBG, Lim ASM. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235-1240.
6. Chen J-K, Tsai RJF, Lin S-S. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol. 1994;30A:243-248.
7. Spandidos DA, Sourvinos G. Kiaris H, Tsamparlakis J. Microsatellite instability and loss of heterozygosity in human pterygia. Br J Ophthalmol. 1997;81:493-496.
8. Gamache DA, Dimitrijevich SD, Weimer LK, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocular Immunol Inflam. 1997;5:117-128.
9. Kennedy M, Kim KH, Brown J, et al. Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci. 1997;38:2483-2491.
10. Cunliffe IA, Richardson PS, Rees RC, Rennie IG. Effect of TNF, IL-1 and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture. Br J Ophthalmol. 1995;79:590-595.
11. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygium. Acta Histochem (Jena). 1996;98:195-201.
12. Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Euk Gene Exp. 1997;7:159-178.
13. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992;7:120-125.
14. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
15. Benaud C, Dickson RB, Thompson EW. Roles of the metalloproteinases in mammary gland development and cancer. Breast Can Res Treat. 1998;50:97-116.
16. Stetler-Stevensen WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 1999; 103:1237-1241.
17. D'Armiento JT, DiColandera T, Dalal SS, et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acantosis and increased susceptibility to tumorigenesis. Mol Cell Biol. 1995; 15:5732-5739.
18. Farina AR, Coppa A, Tiberio A, et al. Transforming growth factor-β 1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer. 1998;75: 721-730.
19. Li D-Q, Tseng SCG. Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by EGF, TGF-α, PDGF-BB and IL-1β. Invest Ophthalmol Vis Sci. 1996; 37:2068-2080.
20. Li D-Q, Tseng SCG. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in cultured human corneal and limbal fibroblasts. J Cell Physiol. 1997;172:361-372.
21. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, Strauss JF III. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol. 1999;154:1755-1762.
22. Li D-Q, Tseng SCG. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
23. Herron GS, Werb Z, Dwyer K, Banda MJ. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of protelytic activity. J Biol Chem. 1986;261:2810-2813.
24. MacNaul KL, Chartain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem. 1990;265: 17238-17245.
25. Rawdanowicz TJ, Hampton Al, Nagase H, Wooley DE, Salamonsen LA. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab. 1994;79:530-536.
26. Jasser MZ, Mitchell PG, Cheung HS. Induction of stromelysin-1 and collagenase synthesis in fibrinochondrocytes by tumor necrosis factor-alpha. Matrix Biol. 1994;14:241-249.
27. Delany AM, Brinckerhoff CE. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem. 1992;50:400-410.
28. Singer CF, Marbaix E, Lemoine P, Courtoy PJ, Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem. 1999;259:40-45.
29. Unemori EN, Ehsani N, Wang M, Lee S, McGuire J, Amento EP Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. Exp Cell Res. 1994;210:166-171.
30. Wilson SE, He Y-G, Lloyd SA. EGF, EGF receptor, basic FGF, TGF-beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
31. Khaw PT, Schultz GS, Mackay SLD, et al. Detection of transforming growth factor-a messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:3302-3306.
32. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest. 1990;97:1439-1445.
33. Thornton SC, Por SB, Walsh BJ, Penny R, Breit SN. Interaction of immune and connective tissue cells: 1. The effect of lymphokines and monokines on fibroblast growth. J Leukocyte Biol. 1990;47: 312-320.
34. Hiraoka A, Sasaguri Y, Komiya S, Inoue A, Morimatsu M. Cell proliferation-related production of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin) by cultured human rheumatoid fibroblasts. Biochem Int. 1992;27:1083-1091.
35. Kumkumian GK, Lafyatis R, Remmers EF, et al. Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription. J Immunol. 1998;143:833-837.
36. Pollanen J, Saksela O, Salonen EM, et al. Distinct localisations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol. 1987;104:1085-1096.
37. Konno H, Tanaka T, Maruo Y, Nakamura S, Baba S, Takada A. Correlation between tumor proliferation and tumor tissue level of urokinase-type plasminogen activator. Eur Surg Res. 1993;25:239-244.
38. Besser D, Presta M, Nagamine Y. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 1995;6:1009-1017.
39. Rotem N, Axelrod JH, Miskin R. Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein. Mol Cell Biol. 1987; 7:622-631.
40. Lee S-B, Li D-Q, Gunja-Smith Z, Liu YQ, Tan DTH, Tseng SCG. Increased expression and activity of MMP-1 and MMP-3 by cultured pterygium head fibroblasts [ARVO abstract]. Invest Ophthalmol Vis Sci. 1999;40(4):S334. Abstract nr 1768.
41. Dinarello CA. Interleukin 1 and its biologically related cytokines. Adv Immunol. 1989;44:153-205.
42. Vilcek J, Palombella VJ, Henriksen-DeStefano D, Swenson C, Feinman R, Hirai M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med. 1986;163:632-643.
43. Vesaluoma M. Teppo A-M, Grönhagen-Riska C, Tervo T. Increased release of tumor necrosis factor-α in human tear fluid after excimer laser induced corneal wound. Br J Ophthalmol. 1997;81:145-149.
44. Malecaze F, Simorre V, Chollet P, et al. Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture [In Process Citation]. Cornea. 1997;16:580-587.
45. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506-2512.
46. Rinne JR, Stulting RD. Current practices in the prevention and treatment of corneal graft rejection Cornea. 1992;11:326-328.
47. Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology 1995;102:718-724.
48. Croasdale CR, Brightbill FS. Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis. Arch Ophthalmol. 1999; 117:966-968.
49. Marionnet AV, Chardonnet Y, Viac J, Schmitt D. Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol. 1997;6:22-28.
50. Goldfeld AE, Flemington EK, Boussiotis VA, et al. Transcription of the tumor necrosis factor alpha gene is rapidly induced by antiimmunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci USA. 1992;89:12198-12201.
51. Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea. 1993;12:413-419.
52. Rojas Silva MV, Rodriguez-Ares MT, Sanchez-Salorio M, et al. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit. Graefes Arch Clin Exp Ophthalmol. 1999;237:840-847.
53. Bagci G. Yucel I, Duranoglu Y. The effect of cyclosporin A on cultured rabbit subconjunctival fibroblast proliferation. Ophthalmologica. 1999;213:114-119.